AcelRx Pharmaceuticals financials at a glance
| Year | Year | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2010 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$1.07M | $2.39M | $29.50M | $5.22M | $19.26M | $17.36M | $8.00M | $2.15M | $2.29M | $5.42M | $2.82M | $0.00M | $0.65M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 10.88% | 0.00% | -25.93% | -94.26% | -276.09% | 0.00% | 0.00% | -25.48% | -0.94% | 0.00% | 100.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | -22.60% | 0.00% | -99.66% | -184.12% | 0.00% | 0.00% | 0.00% | 0.00% | -21.02% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-31.20 | $-23.20 | $-30.20 | $-17.80 | $-20.99 | $-11.00 | $-21.89 | $-22.00 | $-16.20 | $-13.40 | $-9.40 | $-5.80 | $-0.85 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | -0.00% | -0.00% | -0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
19.55m | 35.15m | 43.04m | 43.71m | 44.45m | 45.33m | 50.34m | 74.49m | 79.57m | 98.81m | -473.45m | 8.2m | 16.95m | 0m | 16.95m |
| OCF | Operating Cash Flow |
|
$-15.29M | $-24.58M | $-0.49M | $-34.46M | $-19.95M | $-29.40M | $-29.77M | $-29.08M | $-51.18M | $-38.51M | $-29983000.00M | $-28.33M | $-17.49M | $-12.23M | $0.00M |
| FCF | Free Cash Flow |
|
$-17.31M | $-25.41M | $-3.77M | $-39.96M | $-21.41M | $-33.12M | $-32.17M | $-29.89M | $-54.65M | $-40.36M | $-31810000.00M | $-28.69M | $-17.59M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-1.00 | $-1.15 | $-0.09 | $-0.92 | $-0.48 | $-0.73 | $-0.69 | $-0.51 | $-0.69 | $-0.47 | $-0.27 | $-3.89 | $-1.23 | $-372.46 | $0.00 |